![Guoqing Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Guoqing Chen
Algemeen Directeur bij Advenchen Laboratories LLC
Actieve functies van Guoqing Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Advenchen Laboratories LLC
![]() Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Algemeen Directeur | - | - |
Loopbaan van Guoqing Chen
Eerdere bekende functies van Guoqing Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Elevar Therapeutics, Inc.
![]() Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Directeur/Bestuurslid | 16-09-2019 | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Igenica Biotherapeutics, Inc.
![]() Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Hoofd Techniek/Wetenschap/O&O | 17-02-2010 | - |
Oprichter | 01-01-2008 | - |
Opleiding van Guoqing Chen
University of California, Los Angeles | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Igenica Biotherapeutics, Inc.
![]() Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Advenchen Laboratories LLC
![]() Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Health Technology |
Elevar Therapeutics, Inc.
![]() Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Beurs
- Insiders
- Guoqing Chen
- Ervaring